Target Name: LMCD1
NCBI ID: G29995
Review Report on LMCD1 Target / Biomarker Content of Review Report on LMCD1 Target / Biomarker
LMCD1
Other Name(s): LIM and cysteine rich domains 1, transcript variant 1 | LMCD1 variant 1 | LIM and cysteine-rich domains protein 1 (isoform 1) | LMCD1_HUMAN | Dyxin | LIM and cysteine rich domains 1 | LIM and cysteine-rich domains protein 1 | dyxin

LMCD1: A Protein with Unique LIM and Cysteine-rich Domains That Are Potential Drug and Biomarker Targets

LMCD1, also known as LIM and cysteine-rich domains 1, transcript variant 1, is a protein that is expressed in a variety of tissues and cells throughout the body. It is characterized by the presence of a unique domain that is composed of a combination of limited amino acids, known as the LIM domain, as well as a cysteine-rich domain.

The LIM domain is a unique structural feature that is found in a variety of proteins, including several that are involved in cell signaling pathways. It is composed of a specific sequence of amino acids that is characteristic of LIM proteins. The cysteine-rich domain is also a unique feature that is found in proteins that are involved in the regulation of protein-protein interactions, as well as in the regulation of cell signaling pathways.

LMCD1 is a protein that is expressed in a variety of tissues and cells throughout the body, including the brain, the heart, and the muscles. It is also expressed in various cell types, including neurons, astrocytes, and pericytes. LMCD1 is involved in a number of different cellular processes, including the regulation of cell signaling pathways, the structure and function of organelles, and the regulation of cellular processes that are important for cell survival.

One of the most promising aspects of LMCD1 is its potential as a drug target. The LIM domain and cysteine-rich domain of LMCD1 make it an attractive target for drug development due to their unique structure and function. These domains are involved in the regulation of a wide range of cellular processes, including cell signaling pathways, which makes them an attractive target for drugs that are designed to modulate these processes.

In addition to its potential as a drug target, LMCD1 is also a potential biomarker for a variety of diseases. The LIM domain and cysteine-rich domain of LMCD1 are involved in the regulation of a wide range of cellular processes, including the regulation of cell signaling pathways. This makes them an attractive target for biomarkers that are designed to measure the activity of these processes. For example, LMCD1 has been used as a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Another potential application of LMCD1 is its use as a therapeutic agent. The cysteine-rich domain of LMCD1 is involved in the regulation of cellular processes that are important for cell survival, which makes it an attractive target for therapeutic agents that are designed to modulate these processes. For example, LMCD1 has been shown to be involved in the regulation of cell apoptosis, which is the process by which cells die. This makes it an attractive target for therapeutic agents that are designed to promote or inhibit cell apoptosis.

In conclusion, LMCD1 is a protein that is characterized by the presence of a unique domain that is composed of a combination of limited amino acids, known as the LIM domain, as well as a cysteine-rich domain. It is expressed in a variety of tissues and cells throughout the body and is involved in a number of different cellular processes, including the regulation of cell signaling pathways, the structure and function of organelles, and the regulation of cellular processes that are important for cell survival. The LIM domain and cysteine-rich domain of LMCD1 make it an attractive target for drug development, as well as a potential biomarker and therapeutic agent. Further research is needed to fully understand the role of LMCD1 in cellular processes and its potential as a drug.

Protein Name: LIM And Cysteine Rich Domains 1

Functions: Transcriptional cofactor that restricts GATA6 function by inhibiting DNA-binding, resulting in repression of GATA6 transcriptional activation of downstream target genes. Represses GATA6-mediated trans activation of lung- and cardiac tissue-specific promoters. Inhibits DNA-binding by GATA4 and GATA1 to the cTNC promoter (By similarity). Plays a critical role in the development of cardiac hypertrophy via activation of calcineurin/nuclear factor of activated T-cells signaling pathway

The "LMCD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LMCD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LMCD1-AS1 | LMF1 | LMF2 | LMLN | LMNA | LMNB1 | LMNB2 | LMNTD1 | LMNTD2 | LMNTD2-AS1 | LMO1 | LMO2 | LMO3 | LMO4 | LMO7 | LMO7-AS1 | LMO7DN | LMOD1 | LMOD2 | LMOD3 | LMTK2 | LMTK3 | LMX1A | LMX1B | LMX1B-DT | LNC-LBCS | LNCAROD | LNCARSR | LNCATV | LNCNEF | LNCOC1 | LNCOG | LNCPRESS1 | LNCRI | LNCRNA-ATB | LNCRNA-IUR | LNCTAM34A | LNP1 | LNPEP | LNPK | LNX1 | LNX1-AS1 | LNX2 | LOC100127946 | LOC100127955 | LOC100128002 | LOC100128028 | LOC100128050 | LOC100128059 | LOC100128079 | LOC100128093 | LOC100128164 | LOC100128242 | LOC100128288 | LOC100128317 | LOC100128361 | LOC100128398 | LOC100128494 | LOC100128593 | LOC100128770 | LOC100128966 | LOC100128988 | LOC100129034 | LOC100129098 | LOC100129148 | LOC100129175 | LOC100129203 | LOC100129215 | LOC100129316 | LOC100129381 | LOC100129434 | LOC100129455 | LOC100129534 | LOC100129603 | LOC100129697 | LOC100130000 | LOC100130207 | LOC100130285 | LOC100130298 | LOC100130331 | LOC100130452 | LOC100130463 | LOC100130548 | LOC100130587 | LOC100130691 | LOC100130698 | LOC100130744 | LOC100130748 | LOC100130872 | LOC100130899 | LOC100130938 | LOC100130987 | LOC100130992 | LOC100131096 | LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532